| Utilization of machine learning to create a predictive model for ovarian cancer based on pelvic ultrasound, CA-125, and clinical characteristics |
Graham Chapman |
Case Western Reserve University |
PLCO |
Oct 18, 2022 |
PLCO-1074 |
| Global metabolomics profiling, dietary factors, and colorectal cancer risk in the NIHConsortium of Metabolomics Studies (COMETS) |
Mary Playdon |
University of Utah |
PLCO |
Oct 18, 2022 |
PLCO-1067 |
| Impact of Data Driven Decision Making in Healthcare Analytic |
May Myat |
University of Technology, Yatanarpon Cyber City(UTYCC), Pyin Oo Lwin, Myanmar |
PLCO |
Oct 18, 2022 |
PLCO-1064 |
| Mathematical modelling of prostate cancer data |
Taylor deVet |
McMaster University |
PLCO |
Oct 18, 2022 |
PLCO-1073 |
| Looking for the retrospective link between cigarette habits in men and prostate cancer |
Tamara yaghi |
American international School of riyadh |
PLCO |
Oct 11, 2022 |
PLCO-1071 |
| PREDICTED MORTALITY AS A SURROGATE ENDPOINT IN THE PLCO TRIAL |
Matejka Rebolj |
Queen Mary University of London |
PLCO |
Oct 11, 2022 |
PLCO-1066 |
| Associations between lifestyle factors and colorectal cancer in the PLCO Cancer Screening Trial |
Kerrie Nelson |
Boston University |
PLCO |
Sep 21, 2022 |
PLCO-1053 |
| Class Project Reviewing Correlation between PSA and Prostate Cancer |
Mohamed Yaghi |
Mohamed Yaghi |
PLCO |
Sep 20, 2022 |
PLCO-1054 |
| Multivitamin use and mortality |
Erikka Loftfield |
Erikka Loftfield Cronin |
PLCO |
Sep 19, 2022 |
PLCO-1052 |
| A retrospective study on female-specific characteristics and their association to colorectal cancer using the PLCO Colorectal dataset |
Keerthana Clark |
Eastern Virginia Medical School |
PLCO |
Sep 9, 2022 |
PLCO-1043 |
| Correlates dietary and lifestyle patterns with survival in patients with gastrointestinal cancers |
Christina Grinstead |
University of Florida |
PLCO |
Sep 9, 2022 |
PLCO-1047 |
| Prostate Cancer Cohort Consortium (PC3): A collaborative approach to an enigmatic cancer |
Konrad Stopsack |
Harvard T.H. Chan School of Public Health |
PLCO |
Sep 9, 2022 |
PLCO-1046 |
| Aflatoxin, Polycyclic Aromatic Hydrocarbons, Heavy metals and DNA Methylation in Hepatocellular Carcinoma |
HuiChen Wu |
Columbia University |
PLCO |
Sep 7, 2022 |
2022-0003 |
| The timing between the diagnosis and the end of the last treatment in the cancer continuum in patients with lung cancer by TNM stages; and the impact of delays in the final survival of the patients, in PLCO, In the period available in the data set. |
Percy Guzman |
NCI |
PLCO |
Sep 6, 2022 |
PLCO-1036 |
| Post-diagnosis exercise and mortality risk in cancer survivors |
Jessica Gorzelitz |
University of Iowa |
PLCO |
Sep 6, 2022 |
PLCO-1032 |
| Prostate specific antigen volatility and the diagnosis of clinically significant prostate cancer |
John Leppert |
Stanford University |
PLCO |
Aug 29, 2022 |
PLCO-1034 |
| Metabolic health phenotypes, accelerated biological aging and cancer risk. |
Prasoona Karra |
Geisel School of Medicine at Dartmouth College |
PLCO |
Aug 29, 2022 |
PLCO-1028 |
| Use of PLCO data to evaluate the performance of cancer risk models |
Thomas Ahearn |
Division of Cancer Genetics and Epidemiology, NCI |
PLCO |
Aug 22, 2022 |
PLCO-1025 |
| Data Analysis of Male Breast Cancer |
Vaidehi Gajera |
Western Sydney University |
PLCO |
Aug 22, 2022 |
PLCO-1029 |
| Identifying risk factors for depression and the role of depression in cancer |
Lei Zhang |
Uniformed Services University |
PLCO |
Aug 22, 2022 |
PLCO-1027 |
